CAUDA, ROBERTO
 Distribuzione geografica
Continente #
AS - Asia 1.528
NA - Nord America 86
EU - Europa 42
SA - Sud America 26
AF - Africa 3
OC - Oceania 1
Totale 1.686
Nazione #
SG - Singapore 1.429
US - Stati Uniti d'America 82
CN - Cina 63
HK - Hong Kong 20
BR - Brasile 18
IT - Italia 16
GB - Regno Unito 12
VN - Vietnam 10
CA - Canada 4
AR - Argentina 3
ES - Italia 3
NL - Olanda 3
DE - Germania 2
JP - Giappone 2
PL - Polonia 2
VE - Venezuela 2
AO - Angola 1
AU - Australia 1
CO - Colombia 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
FR - Francia 1
ID - Indonesia 1
IE - Irlanda 1
IL - Israele 1
LU - Lussemburgo 1
MA - Marocco 1
PK - Pakistan 1
PS - Palestinian Territory 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 1.686
Città #
Singapore 33
Hefei 24
Hong Kong 20
Ashburn 19
Beijing 16
Boardman 15
London 11
Rome 8
Shanghai 7
Hanoi 4
Ho Chi Minh City 4
Los Angeles 4
Amsterdam 3
Brooklyn 3
Fort Worth 3
Washington 3
Chicago 2
Council Bluffs 2
Dallas 2
Guangzhou 2
Munich 2
San Francisco 2
Seattle 2
Warsaw 2
West Jordan 2
Atlanta 1
Augusta 1
Boston 1
Brasília 1
Bucaramanga 1
Campo Belo 1
Cardenal 1
Carúpano 1
Cesano Maderno 1
Chongqing 1
Curitiba 1
Dublin 1
Guarabira 1
Guayaquil 1
Ha Long 1
Ibatiba 1
Igarapé 1
Imbituva 1
Islamabad 1
Jacksonville 1
Jihlava 1
Jining 1
Johannesburg 1
José C. Paz 1
Luanda 1
Luxembourg 1
Maldonado 1
Morada Nova 1
Ottawa 1
Patos de Minas 1
Pedregulho 1
Prospect 1
Puerto Cabello 1
Ramat Gan 1
Recreo 1
Rio de Janeiro 1
San Luis 1
Santa Clara 1
Santa Luzia 1
Serrinha 1
Shenyang 1
Shirasagi 1
Sona 1
Sorocaba 1
South Tangerang 1
Sydney 1
São Bernardo do Campo 1
São Paulo 1
The Dalles 1
Tokyo 1
Toronto 1
Valsamoggia 1
Vinhedo 1
Xi'an 1
Totale 249
Nome #
Ethical criteria for the admission and management of patients in the ICU under conditions of limited medical resources: a shared international proposal in view of the COVID-19 pandemic 187
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 182
SARS‐CoV‐2 B.1.617 Indian variants: Are electrostatic potential changes responsible for a higher transmission rate? 180
The SARS‐CoV‐2 Mu variant should not be left aside: It warrants attention for its immuno‐escaping ability 178
The role of procalcitonin outside of the Intensive Care Unit (ICU): a multidisciplinary approach 175
Genetic and Structural Data on the SARS-CoV-2 Omicron BQ.1 Variant Reveal Its Low Potential for Epidemiological Expansion 163
Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission 156
Shortening Epitopes to Survive: The Case of SARS-CoV-2 Lambda Variant 156
Molecular In-Depth on the Epidemiological Expansion of SARS-CoV-2 XBB.1.5 90
Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy 83
SARS-CoV-2 shifting transmission dynamics and hidden reservoirs potentially limit efficacy of public health interventions in Italy 73
Genetic and structural genome-based survey reveals the low potential for epidemiological expansion of the SARS-CoV-2 XBB.1.5 sublineage 53
SARS-CoV-2 XEC: A Genome-Based Survey 10
Genome-based comparison between the recombinant SARS-CoV-2 XBB and its parental lineages 8
The Biological Properties of the SARS-CoV-2 Cameroon Variant Spike: An Intermediate between the Alpha and Delta Variants 4
Totale 1.698
Categoria #
all - tutte 5.558
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.558


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202210 0 0 0 0 0 0 1 0 0 0 0 9
2022/20237 1 0 0 0 0 2 0 0 0 0 4 0
2023/202443 1 4 9 6 7 12 0 1 1 2 0 0
2024/20251.472 13 2 16 5 2 12 5 0 33 68 658 658
2025/2026166 40 22 16 44 28 16 0 0 0 0 0 0
Totale 1.698